GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
7.70743 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.38333 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
7.11208 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.11208 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.11208 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, SMAD3, SRC, TEK, TOP1, TYR |
6.81556 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.77091 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.66842 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.55084 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPRS, SLC5A2, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.47654 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.47654 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
6.30447 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.6615 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.61799 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.61799 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.59309 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, SRC, TEK |
5.58954 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, AOX1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, HSPA1A, PIM1, PPARA, TYR, XDH |
5.57232 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.49119 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.38917 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, PPARA, SRC, TEK, TYR |
5.24965 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, PPARA, SMAD3, SRC, TEK |
5.2216 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, XDH |
5.19684 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, SRC, TYR |
5.19684 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.15831 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.87164 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, INSR, KDR, MET, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS2, TYR |
4.75659 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS, TOP1 |
4.72913 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, AURKB, AXL, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SRC, TEK, TNKS, TOP1, XDH |
4.72709 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.67591 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.59277 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.56699 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
4.56347 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AXL, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, SRC, TEK, XDH |
4.55376 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, SRC |
4.55376 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPRS, SLC5A2, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
4.49891 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, AURKB, AXL, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SRC, TEK, TNKS, TOP1, XDH |
4.45879 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, SRC, TEK, TYR |
4.40556 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS, TOP1 |
4.32985 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX15, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, HSD17B2, IGF1R, INSR, MET, MMP12, PIM1, PPARA, SLC5A1, SMAD3, SRC, TEK, TNKS2, TOP1, TYR |
4.29653 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TYR |
4.29653 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK, XDH |
4.26684 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA2, CA4, CA7, CA9 |
4.22741 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.0878 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
4.05795 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR |
4.05795 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, SMAD3, SRC, TEK |
3.98337 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.9794 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.97494 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.97494 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
3.97494 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, CYP19A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
3.95722 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, MET, PPARA |
3.95722 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPRS, SLC5A2, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
3.90591 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.88594 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.87181 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.8557 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS, TOP1 |
3.85225 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.79835 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MET, PIM1, SMAD3, SRC, TEK, XDH |
3.79161 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.79045 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PIM1, SMAD3, SRC, TEK |
3.73964 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
3.60047 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.59073 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.57051 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK |
3.54819 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
3.37711 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.37711 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
3.37474 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.29894 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
3.29894 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, SMAD3, SRC |
3.29894 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PPARA, SMAD3, SRC, TEK, TOP1, TYR |
3.29894 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
3.29894 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.27496 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.27496 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, PIM1, SMAD3, SRC, TEK, XDH |
3.24356 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.21531 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.15777 |
[BP] GO:0030335 |
positive regulation of cell migration
|
EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.12441 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
3.12195 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, PIM1, SMAD3, SRC, TEK |
3.12195 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.03558 |
[BP] GO:2000147 |
positive regulation of cell motility
|
EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.02133 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, SMAD3, SRC |
2.99807 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, SRC, TOP1 |
2.97543 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.96852 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.94915 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.94915 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.94915 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.91745 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.89744 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.89744 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.89464 |
[BP] GO:0040017 |
positive regulation of locomotion
|
EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.85658 |
[BP] GO:0030334 |
regulation of cell migration
|
CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.83233 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.83233 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.82833 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.82833 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.82833 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.82833 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.82833 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
2.8187 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.81532 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
2.80915 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, EGFR, ESR1, FABP4, KDR, MET, MMP12, PPARA, PTPRS, SMAD3, TEK |
2.80858 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
2.79775 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK |
2.79354 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 |
2.78852 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.77904 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD17B1, HSD17B2 |
2.76913 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.73837 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.73731 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, SRC |
2.72969 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.71731 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.71731 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.71629 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, AURKB, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.71629 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, PPARA, SRC, TOP1 |
2.69981 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.6962 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.69501 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A |
2.67448 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.67391 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.67391 |
[BP] GO:2000145 |
regulation of cell motility
|
CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.6631 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
2.65745 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.65159 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
2.64778 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, PIM1, PPARA, SRC, TNKS |
2.64683 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, AURKB, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TNKS, XDH |
2.64035 |
[BP] GO:0006464 |
cellular protein modification process
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.63993 |
[BP] GO:0036211 |
protein modification process
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.63993 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, SMAD3, SRC |
2.6359 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
2.6359 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.60937 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.57973 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.56352 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.56352 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.56352 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.56352 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.53685 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.53007 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.51283 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.50467 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK, XDH |
2.46607 |
[BP] GO:0035428 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.45719 |
[BP] GO:1904659 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.45719 |
[BP] GO:1905950 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.45719 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.45719 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.45204 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, PIM1, TEK |
2.44428 |
[BP] GO:0040012 |
regulation of locomotion
|
CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.42173 |
[BP] GO:0051270 |
regulation of cellular component movement
|
CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.41052 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41008 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.36124 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.36124 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36124 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, TNKS, TNKS2 |
2.35575 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AURKB, AXL, CSNK2A1, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.32893 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.32893 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.32893 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.32893 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.32893 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK, TYR |
2.30677 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.29088 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.28007 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.28007 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, KDR, SRC, TNKS, TNKS2 |
2.27066 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.26213 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.25083 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.24123 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.23335 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.23335 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.23244 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.22509 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, SMAD3, SRC, TEK |
2.22343 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPR35, HSPA1A, INSR, KDR, MET, MMP12, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
2.219 |
[BP] GO:0034219 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.21011 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.21011 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.18996 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.13229 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.13229 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.12046 |
[BP] GO:0040008 |
regulation of growth
|
CSNK2A1, EGFR, ESR2, HSPA1A, INSR, PIM1, PTPRS, SMAD3, TNKS2 |
2.12046 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.10418 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, INSR, KDR, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS2, XDH |
2.10418 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, EGFR, FLT3, INSR, KDR, SRC, TEK, XDH |
2.10105 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.10105 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
AURKB, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TNKS |
2.09879 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK, TYR |
2.09137 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.08814 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, AURKB, AXL, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.07904 |
[BP] GO:0043412 |
macromolecule modification
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.07904 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
2.06681 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, CA2, CYP1A1, EGFR, HSPA1A, PPARA, SMAD3, SRC, TEK, TYR |
2.06248 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.06248 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.04327 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.04327 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.03863 |
[BP] GO:0044267 |
cellular protein metabolic process
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.03361 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.03361 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, XDH |
2.02752 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.02752 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.02752 |
[BP] GO:0032212 |
positive regulation of telomere maintenance via telomerase
|
AURKB, TNKS, TNKS2 |
2.01536 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.01135 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, KDR, SRC, TEK |
2.01135 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.01111 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.00292 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ALOX15, AXL, CA2, CA4, CA9, DUSP3, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SLC5A1, SLC5A2, SLC5A4, SRC, TEK |
2.96324 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
AXL, CA4, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SLC5A1, SLC5A2, SLC5A4, TEK |
2.32893 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, AKR1B1, AOX1, AURKB, AXL, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PIM1, PPARA, PTPRS, SLC5A1, SLC5A2, SMAD3, SRC, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
2.24123 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, AKR1B1, ALOX15, AOX1, AURKB, AXL, CA2, CA4, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PIM1, PPARA, PTPRS, SLC5A1, SLC5A2, SMAD3, SRC, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
2.07904 |
[CC] GO:0016323 |
basolateral plasma membrane
|
CA2, CA4, CA9, EGFR, TEK |
1.87545 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
10.423 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP12, PIM1, PPARA, SMAD3, TNKS, TYR, XDH |
10.423 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, ALOX15, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, F10, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PTPRS, SRC, TEK, TNKS, TNKS2, TOP1, TUBB3, TYR, XDH |
8.44432 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.47847 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.90812 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA2, CA4, CA7, CA9 |
6.25789 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP1 |
6.20261 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.66152 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
5.60556 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
4.99478 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, AURKB, AXL, CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SRC, TEK, TOP1, TUBB3, XDH |
4.90453 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.79398 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.43379 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
4.39325 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.02412 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.02412 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3, XDH |
3.98588 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP12, PPARA, SMAD3, TNKS |
3.97494 |
[MF] GO:0005412 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
3.88762 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA2, CA4, CA7, CA9 |
3.85707 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.85489 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3, XDH |
3.80571 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3, XDH |
3.80571 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.78698 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.7564 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.68258 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.37711 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.31845 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA2, CA4, CA7, CA9 |
3.29894 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, CBR1, HSD17B1, HSD17B2, XDH |
3.29894 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, PPARA |
3.26778 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.23633 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, PIM1, PPARA, SMAD3, SRC |
3.22189 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.21089 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AOX1, AURKB, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP12, NUAK1, PIM1, PPARA, SMAD3, TNKS, TNKS2, TYR, XDH |
3.20201 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.10178 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
3.08036 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AOX1, AURKB, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, MMP12, NUAK1, PIM1, PPARA, SMAD3, TNKS, TNKS2, TYR, XDH |
2.95127 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3 |
2.94915 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.91275 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.89464 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.89371 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3 |
2.842 |
[MF] GO:0017076 |
purine nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3 |
2.82833 |
[MF] GO:0032553 |
ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TUBB3 |
2.82269 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
2.77108 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.72969 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPRS, SRC, TEK, TOP1, TUBB3 |
2.64944 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.58129 |
[MF] GO:0005355 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.50467 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.45798 |
[MF] GO:0015149 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.45719 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.44294 |
[MF] GO:0015145 |
None
|
SLC5A1, SLC5A2, SLC5A4 |
2.36124 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.33742 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.32893 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PTPRS, SRC, TEK, TOP1 |
2.26164 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
2.2375 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, SRC, XDH |
2.23335 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.16833 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.15451 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.15442 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.15442 |
[MF] GO:0004872 |
receptor activity
|
AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.13002 |
[MF] GO:0001047 |
None
|
ESR1, ESR2, ESRRB, MMP12, TOP1 |
2.03361 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, SMAD3, SRC |
2.03361 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.02752 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.02725 |